Cumberland Pharmaceuticals Stock Price History
| CPIX Stock | USD 4.46 0.00 0.00% |
Below is the normalized historical share price chart for Cumberland Pharmaceuticals extending back to August 11, 2009. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cumberland Pharmaceuticals stands at 4.46, as last reported on the 24th of March, with the highest price reaching 4.95 and the lowest price hitting 4.46 during the day.
If you're considering investing in Cumberland Stock, it is important to understand the factors that can impact its price. Cumberland Pharmaceuticals is dangerous given 3 months investment horizon. Cumberland Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.69% are justified by taking the suggested risk. Use Cumberland Pharmaceuticals Mean Deviation of 7.63, risk adjusted performance of 0.1235, and Downside Deviation of 7.02 to evaluate company specific risk that cannot be diversified away.
At this time, Cumberland Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 79.4 T in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 13.4 M in 2025. . Price To Sales Ratio is likely to drop to 0.84 in 2025. Price Earnings Ratio is likely to rise to -4.89 in 2025. Cumberland Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of August 2009 | 200 Day MA 2.1632 | 50 Day MA 4.2754 | Beta (0.18) |
Cumberland |
Sharpe Ratio = 0.1272
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | CPIX | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 13.26 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.69 actual daily | 34 66% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Cumberland Pharmaceuticals is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cumberland Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 2.7871 | Enterprise Value Ebitda 363.4655 | Price Sales 1.6931 | Shares Float 6.5 M | Wall Street Target Price 8.5 |
Cumberland Pharmaceuticals Stock Price History Chart
There are several ways to analyze Cumberland Stock price data. The simplest method is using a basic Cumberland candlestick price chart, which shows Cumberland Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 5, 2025 | 6.77 |
| Lowest Price | February 3, 2025 | 2.13 |
Cumberland Pharmaceuticals March 24, 2025 Stock Price Synopsis
Various analyses of Cumberland Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cumberland Stock. It can be used to describe the percentage change in the price of Cumberland Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cumberland Stock.| Cumberland Pharmaceuticals Price Rate Of Daily Change | 1.00 | |
| Cumberland Pharmaceuticals Price Action Indicator | (0.25) |
Cumberland Pharmaceuticals March 24, 2025 Stock Price Analysis
Cumberland Stock Price History Data
The price series of Cumberland Pharmaceuticals for the period between Tue, Dec 24, 2024 and Mon, Mar 24, 2025 has a statistical range of 4.65 with a coefficient of variation of 39.76. The prices are distributed with arithmetic mean of 3.8. The median price for the last 90 days is 3.76. The company had 2:1 stock split on 6th of July 2007. Cumberland Pharmaceuticals issued dividends on 2010-10-29.| Open | High | Low | Close | Volume | ||
03/24/2025 | 4.46 | 4.95 | 4.46 | 4.46 | ||
03/24/2025 | 4.46 | 4.95 | 4.46 | 4.46 | ||
| 03/21/2025 | 4.90 | 4.95 | 4.55 | 4.59 | 85,495 | |
| 03/20/2025 | 5.04 | 5.32 | 4.80 | 4.88 | 145,490 | |
| 03/19/2025 | 5.24 | 5.49 | 4.94 | 5.07 | 45,634 | |
| 03/18/2025 | 5.00 | 5.24 | 4.96 | 5.14 | 40,311 | |
| 03/17/2025 | 5.55 | 5.60 | 5.17 | 5.17 | 23,965 | |
| 03/14/2025 | 5.47 | 5.57 | 5.17 | 5.46 | 45,268 | |
| 03/13/2025 | 5.59 | 5.59 | 5.19 | 5.49 | 52,748 | |
| 03/12/2025 | 5.27 | 5.60 | 5.04 | 5.57 | 59,969 | |
| 03/11/2025 | 4.93 | 5.30 | 4.64 | 5.17 | 124,894 | |
| 03/10/2025 | 6.39 | 6.39 | 4.75 | 4.99 | 205,686 | |
| 03/07/2025 | 6.64 | 6.70 | 6.00 | 6.37 | 84,046 | |
| 03/06/2025 | 6.81 | 6.89 | 6.18 | 6.61 | 211,360 | |
| 03/05/2025 | 5.75 | 7.25 | 5.56 | 6.77 | 725,129 | |
| 03/04/2025 | 5.09 | 6.35 | 4.71 | 6.05 | 402,205 | |
| 03/03/2025 | 4.89 | 5.75 | 4.89 | 5.14 | 412,088 | |
| 02/28/2025 | 4.94 | 5.07 | 4.68 | 4.86 | 62,522 | |
| 02/27/2025 | 5.32 | 5.32 | 4.84 | 4.97 | 39,401 | |
| 02/26/2025 | 5.01 | 5.35 | 4.95 | 5.19 | 191,944 | |
| 02/25/2025 | 4.77 | 5.10 | 4.63 | 4.87 | 179,427 | |
| 02/24/2025 | 5.25 | 5.39 | 5.00 | 5.04 | 159,938 | |
| 02/21/2025 | 5.75 | 6.05 | 5.31 | 5.31 | 168,177 | |
| 02/20/2025 | 6.18 | 6.18 | 5.59 | 5.95 | 318,530 | |
| 02/19/2025 | 4.94 | 7.19 | 4.84 | 6.19 | 1,488,588 | |
| 02/18/2025 | 5.30 | 5.30 | 4.60 | 4.82 | 312,877 | |
| 02/14/2025 | 4.75 | 5.24 | 4.60 | 5.15 | 179,053 | |
| 02/13/2025 | 5.28 | 5.28 | 4.64 | 4.64 | 153,096 | |
| 02/12/2025 | 4.64 | 5.29 | 4.52 | 5.20 | 263,267 | |
| 02/11/2025 | 4.60 | 5.23 | 4.52 | 4.60 | 297,831 | |
| 02/10/2025 | 4.34 | 4.70 | 4.12 | 4.52 | 386,342 | |
| 02/07/2025 | 5.22 | 5.25 | 4.42 | 4.47 | 1,128,791 | |
| 02/06/2025 | 5.14 | 6.10 | 5.10 | 5.34 | 3,045,968 | |
| 02/05/2025 | 3.84 | 6.43 | 3.84 | 5.08 | 60,155,267 | |
| 02/04/2025 | 2.35 | 3.79 | 2.21 | 3.76 | 18,486,900 | |
| 02/03/2025 | 2.16 | 2.26 | 2.08 | 2.13 | 59,505 | |
| 01/31/2025 | 2.29 | 2.38 | 2.21 | 2.26 | 40,568 | |
| 01/30/2025 | 2.20 | 2.52 | 2.20 | 2.25 | 23,381 | |
| 01/29/2025 | 2.33 | 2.38 | 2.21 | 2.24 | 20,209 | |
| 01/28/2025 | 2.32 | 2.50 | 2.30 | 2.36 | 24,970 | |
| 01/27/2025 | 2.46 | 2.53 | 2.33 | 2.36 | 24,779 | |
| 01/24/2025 | 2.57 | 2.59 | 2.45 | 2.59 | 10,371 | |
| 01/23/2025 | 2.63 | 2.63 | 2.50 | 2.50 | 26,019 | |
| 01/22/2025 | 2.41 | 2.63 | 2.41 | 2.62 | 26,533 | |
| 01/21/2025 | 2.52 | 2.60 | 2.43 | 2.43 | 57,030 | |
| 01/17/2025 | 2.81 | 2.84 | 2.50 | 2.53 | 67,980 | |
| 01/16/2025 | 2.73 | 2.95 | 2.70 | 2.77 | 127,831 | |
| 01/15/2025 | 2.62 | 2.98 | 2.50 | 2.74 | 366,373 | |
| 01/14/2025 | 2.30 | 3.93 | 2.29 | 2.67 | 7,471,471 | |
| 01/13/2025 | 2.34 | 2.38 | 2.27 | 2.33 | 22,194 | |
| 01/10/2025 | 2.24 | 2.40 | 2.23 | 2.33 | 99,775 | |
| 01/08/2025 | 2.38 | 2.38 | 2.21 | 2.23 | 40,798 | |
| 01/07/2025 | 2.35 | 2.50 | 2.26 | 2.37 | 118,528 | |
| 01/06/2025 | 2.34 | 2.34 | 2.26 | 2.29 | 60,276 | |
| 01/03/2025 | 2.21 | 2.37 | 2.18 | 2.30 | 100,267 | |
| 01/02/2025 | 2.44 | 2.44 | 2.23 | 2.23 | 67,838 | |
| 12/31/2024 | 2.51 | 2.53 | 2.30 | 2.37 | 213,943 | |
| 12/30/2024 | 2.34 | 2.55 | 2.27 | 2.42 | 84,299 | |
| 12/27/2024 | 2.39 | 2.40 | 2.24 | 2.32 | 82,964 | |
| 12/26/2024 | 2.54 | 2.54 | 2.28 | 2.35 | 157,887 | |
| 12/24/2024 | 2.23 | 2.59 | 2.23 | 2.51 | 170,463 |
About Cumberland Pharmaceuticals Stock history
Cumberland Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cumberland is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cumberland Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cumberland Pharmaceuticals stock prices may prove useful in developing a viable investing in Cumberland Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 14.1 M | 13.4 M | |
| Net Loss | -5 M | -4.8 M |
Cumberland Pharmaceuticals Quarterly Net Working Capital |
|
Cumberland Pharmaceuticals Stock Technical Analysis
Cumberland Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Cumberland Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cumberland Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Cumberland Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cumberland to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1235 | |||
| Jensen Alpha | 1.76 | |||
| Total Risk Alpha | 2.64 | |||
| Sortino Ratio | 0.2458 | |||
| Treynor Ratio | 1.13 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Cumberland Stock Analysis
When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.